FFCP PHASE1:Mm9::chr12:87383737..87383759,-: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|EntrezGene=NA|HGNC=|MCL_coexpression_id=50|UniProt=NA|association_with_transcript=NA|description=CAGE_peak_at_chr12:87383737..87383759,-|id=chr12:87383737..87383759,-|ontology_enrichment_celltype=|ontology_enrichment_celltype_v019_2=CL:0000084,5.67e-17,11;CL:0000827,5.67e-17,11;CL:0000838,1.13e-15,12;CL:0000542,1.42e-14,13;CL:0000051,1.42e-14,13;CL:0000738,1.86e-11,17;CL:0002087,1.86e-11,17;CL:0002031,3.41e-08,25|ontology_enrichment_disease=|ontology_enrichment_disease_v019_2=|ontology_enrichment_uberon=UBERON:0002370!1.96e-10!23;UBERON:0000974!1.96e-10!23;UBERON:0004807!1.96e-10!23;UBERON:0005058!1.96e-10!23;UBERON:0003351!1.96e-10!23;UBERON:0009113!1.96e-10!23;UBERON:0003295!1.96e-10!23;UBERON:0009722!1.96e-10!23;UBERON:0005562!1.96e-10!23;UBERON:0007690!1.96e-10!23;UBERON:0006562!5.49e-10!24;UBERON:0003408!5.49e-10!24;UBERON:0001557!5.49e-10!24;UBERON:0001042!5.49e-10!24;UBERON:0008814!5.49e-10!24;UBERON:0009145!5.49e-10!24;UBERON:0000072!7.63e-09!27;UBERON:0004177!3.27e-08!29;UBERON:0000063!9.55e-07!35|ontology_enrichment_uberon_v019_2=|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6.55320277925843,8.35839325244593,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.239630249011841,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.199034266818493,0,0,0,0,0,0,0,0,0,0,0,0,0,0.164167464079095,0,0,0,0,0,0,0.330418782983798,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.138199973804424,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.316011120628178,0.202725215290164,0.924398614483445,0.649604114888975,0.358053391334963,0,0,0.147689527174577,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0|short_description=p@chr12:87383737..87383759,-}} | {{FFCP | ||
|DHSsupport=NA | |||
|DPIdataset=NA | |||
|EntrezGene=NA | |||
|HGNC= | |||
|MCL_coexpression_id=50 | |||
|TSSclassifier=NA | |||
|UniProt=NA | |||
|association_with_transcript=NA | |||
|cluster_id=chr12:87383737..87383759,- | |||
|description=CAGE_peak_at_chr12:87383737..87383759,- | |||
|id=chr12:87383737..87383759,- | |||
|ontology_enrichment_celltype= | |||
|ontology_enrichment_celltype_v019_2=CL:0000084,5.67e-17,11;CL:0000827,5.67e-17,11;CL:0000838,1.13e-15,12;CL:0000542,1.42e-14,13;CL:0000051,1.42e-14,13;CL:0000738,1.86e-11,17;CL:0002087,1.86e-11,17;CL:0002031,3.41e-08,25 | |||
|ontology_enrichment_disease= | |||
|ontology_enrichment_disease_v019_2= | |||
|ontology_enrichment_uberon=UBERON:0002370!1.96e-10!23;UBERON:0000974!1.96e-10!23;UBERON:0004807!1.96e-10!23;UBERON:0005058!1.96e-10!23;UBERON:0003351!1.96e-10!23;UBERON:0009113!1.96e-10!23;UBERON:0003295!1.96e-10!23;UBERON:0009722!1.96e-10!23;UBERON:0005562!1.96e-10!23;UBERON:0007690!1.96e-10!23;UBERON:0006562!5.49e-10!24;UBERON:0003408!5.49e-10!24;UBERON:0001557!5.49e-10!24;UBERON:0001042!5.49e-10!24;UBERON:0008814!5.49e-10!24;UBERON:0009145!5.49e-10!24;UBERON:0000072!7.63e-09!27;UBERON:0004177!3.27e-08!29;UBERON:0000063!9.55e-07!35 | |||
|ontology_enrichment_uberon_v019_2= | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6.55320277925843,8.35839325244593,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.239630249011841,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.199034266818493,0,0,0,0,0,0,0,0,0,0,0,0,0,0.164167464079095,0,0,0,0,0,0,0.330418782983798,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.138199973804424,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.316011120628178,0.202725215290164,0.924398614483445,0.649604114888975,0.358053391334963,0,0,0.147689527174577,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p@chr12:87383737..87383759,- | |||
}} |
Latest revision as of 10:25, 5 August 2015
Short description: | p@chr12:87383737..87383759, - |
---|---|
Species: | Mouse (Mus musculus) |
DPI dataset: | NA |
TSS-like-by-RIKEN-classifier(Yes/No): | NA |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_at_chr12:87383737..87383759, - |
Coexpression cluster: | MCL_coexpression_mm9:50 |
Association with transcript: | NA |
EntrezGene: | NA |
Link to Zenbu: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
T cell | 5.67e-17 | 11 |
pro-T cell | 5.67e-17 | 11 |
lymphoid lineage restricted progenitor cell | 1.13e-15 | 12 |
lymphocyte | 1.42e-14 | 13 |
common lymphoid progenitor | 1.42e-14 | 13 |
leukocyte | 1.86e-11 | 17 |
nongranular leukocyte | 1.86e-11 | 17 |
hematopoietic lineage restricted progenitor cell | 3.41e-08 | 25 |